Lasmiditan is a DEA Schedule V controlled substance. Substances in the DEA Schedule V have a low potential for abuse relative to substances listed in Schedule IV and consist mainly of preparations containing limited quantities of certain narcotics. It is a Depressants substance. It is grouped under the following drug class(es): Schedule V controlled substances and Serotonin agents. Its therapeutic use is listed as analgesics and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Lasmiditanum and Reyvow. It is listed as a controlled drug substance (Schedule V). Its PubChem CID is 11610526.
Lasmiditan
| CAS No | 439239-90-4 |
|---|---|
| Molecular Formula | C19H18F3N3O2 |
| Molecular Weight | 377.40 g/mol |
| Synonyms | 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)pyridin-2-yl]benzamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lasmiditan is a DEA Schedule V controlled substance. Substances in the DEA Schedule V have a low potential for abuse relative to substances listed in Schedule IV and consist mainly of preparations containing limited quantities of certain narcotics.
The listed CAS number is 439239-90-4.
The listed molecular formula is C19H18F3N3O2.
The listed molecular weight is 377.40 g/mol.
2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)pyridin-2-yl]benzamide.
The source lists Lasmiditanum and Reyvow.